Methods for nicotine replacement dosage determination
US6602892B1 · kind B1 · utility
14Cited by
2References
10Claims
0Family size
Inventor
Key dates
| Filing date | Apr 13, 1995 |
| Grant date | Aug 5, 2003 |
| Priority date | — |
| Expiry date | Apr 13, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/17
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for predicting nicotine replacement dosage to achieve a target nicotine serum concentration relies on measuring blood nicotine concentration prior to smoking cessation. At least two values corresponding to other patient characteristics, such as body mass, cumulative smoking, psychological dependence, age, and menopausal status, are also determined and used to predict expected blood nicotine concentrations based on nicotine replacement dosages. Such methods are useful in achieving target blood nicotine concentrations for smoking cessation and therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.